LILLY'S ORFORGLIPRON HELPED PEOPLE MAINTAIN WEIGHT LOSS AFTER SWITCHING FROM INJECTABLE INCRETINS TO ORAL GLP-1 THERAPY IN FIRST-OF-ITS-KIND PHASE 3 TRIAL

Reuters · 2d ago

Please log in to view news